Total Payments
$487.05
2024 Payments
$171.99
Companies
8
Transactions
28
Medicare Patients
975
Medicare Billing
$67,150
Payment Breakdown by Category
Food & Beverage$487.05 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $487.05 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $144.89 | 7 | $0 (2024) |
| Novo Nordisk Inc | $114.25 | 7 | $0 (2023) |
| AbbVie Inc. | $67.75 | 5 | $0 (2021) |
| Lilly USA, LLC | $63.09 | 4 | $0 (2023) |
| Ultragenyx Pharmaceutical Inc. | $31.16 | 1 | $0 (2021) |
| Corcept Therapeutics | $27.10 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $26.16 | 2 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $12.65 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $171.99 | 8 | AstraZeneca Pharmaceuticals LP ($144.89) |
| 2023 | $49.79 | 3 | Novo Nordisk Inc ($30.82) |
| 2022 | $48.15 | 3 | Novo Nordisk Inc ($30.54) |
| 2021 | $217.12 | 14 | AbbVie Inc. ($67.75) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Respiratory | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $28.58 | General |
| Category: Respiratory | ||||||
| 05/30/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: Endocrinology | ||||||
| 04/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: Respiratory | ||||||
| 04/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/26/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Diabetes | ||||||
| 08/17/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Diabetes | ||||||
| 06/06/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Diabetes | ||||||
| 07/13/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Diabetes | ||||||
| 03/02/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Diabetes | ||||||
| 01/11/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Diabetes | ||||||
| 11/02/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Diabetes | ||||||
| 10/27/2021 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $31.16 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 09/21/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Diabetes | ||||||
| 09/09/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: DIABETES | ||||||
| 07/14/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Diabetes | ||||||
| 06/29/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: RESPIRATORY | ||||||
| 05/25/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: NEUROSCIENCE | ||||||
| 04/13/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: NEUROSCIENCE | ||||||
| 03/31/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 323 | 688 | $92,320 | $23,019 |
| 2022 | 10 | 287 | 766 | $90,525 | $23,405 |
| 2021 | 11 | 272 | 541 | $67,638 | $17,104 |
| 2020 | 6 | 93 | 107 | $13,199 | $3,622 |
Total Patients
975
Total Services
2,102
Medicare Billing
$67,150
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 235 | $73,729 | $16,677 | 22.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $7,133 | $1,504 | 21.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 31 | 43 | $1,875 | $1,377 | 73.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 31 | 60 | $1,500 | $973.20 | 64.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 15 | 15 | $700.00 | $686.00 | 98.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 14 | $3,019 | $571.10 | 18.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 40 | 51 | $765.00 | $428.40 | 56.0% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 18 | 22 | $536.00 | $356.40 | 66.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 33 | $1,341 | $244.48 | 18.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 26 | 152 | $1,132 | $112.92 | 10.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 24 | 40 | $591.00 | $88.00 | 14.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 65 | 214 | $67,140 | $15,576 | 23.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 30 | 51 | $2,550 | $1,778 | 69.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 30 | 30 | $9,303 | $1,684 | 18.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 31 | 102 | $2,550 | $1,666 | 65.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 18 | $3,881 | $925.84 | 23.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 31 | 67 | $2,724 | $551.70 | 20.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 14 | 14 | $560.00 | $548.80 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 14 | 14 | $569.10 | $380.38 | 66.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 27 | 216 | $648.00 | $176.61 | 27.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 31 | 40 | $600.00 | $117.75 | 19.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 149 | $46,747 | $11,039 | 23.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 37 | 37 | $11,474 | $2,414 | 21.0% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 18 | 25 | $1,250 | $883.25 | 70.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 12 | $2,587 | $710.76 | 27.5% |
About Kitty Van Meter, NP
Kitty Van Meter, NP is a Family healthcare provider based in Camilla, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1902005358.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kitty Van Meter, NP has received a total of $487.05 in payments from pharmaceutical and medical device companies, with $171.99 received in 2024. These payments were reported across 28 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($487.05).
As a Medicare-enrolled provider, Van Meter has provided services to 975 Medicare beneficiaries, totaling 2,102 services with total Medicare billing of $67,150. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Camilla, GA
- Active Since 07/16/2007
- Last Updated 05/23/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1902005358
Products in Payments
- AIRSUPRA (Drug) $73.41
- FARXIGA (Drug) $71.48
- Ozempic (Drug) $61.66
- TRULICITY (Drug) $45.48
- UBRELVY (Drug) $43.78
- Crysvita (Drug) $31.16
- Rybelsus (Drug) $30.54
- Korlym (Drug) $27.10
- TRELEGY ELLIPTA (Drug) $26.16
- VRAYLAR (Drug) $23.97
- RYBELSUS (Drug) $22.05
- MOUNJARO (Drug) $17.61
- JARDIANCE (Drug) $12.65
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Camilla
Heather Anderson
Family — Payments: $1,583
Family $1,583
Casidy Enfinger, Np-C, NP-C
Family — Payments: $1,265
Family $1,265
Magan Gilliam, Np, NP
Family — Payments: $359.35
Family $359.35
Mr. Antonio Miller, Rn, RN
Family — Payments: $331.34
Family $331.34
Ashley Abt, Pa, PA
Family — Payments: $215.71
Family $215.71
Christine Lockhart, Cnp, CNP
Family — Payments: $124.61
Family $124.61